Claudio Vernieri
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Oncology 60
- HER2/EGFR in Cancer Research 12
- Cancer Immunotherapy and Biomarkers 11
-
- Breast Cancer Treatment Studies 15
- Cancer Genomics and Diagnostics 11
- Co-authors
- Filippo Guglielmo Maria de Braud (46 shared papers)Valter Daniel Longo (5 shared papers)Francesca Ligorio (22 shared papers)Riccardo Lobefaro (14 shared papers)Marco Foiani (5 shared papers)Andrea Ciliberto (4 shared papers)Emma Zattarin (15 shared papers)Giulia Bianchi (18 shared papers)
- Journals
- Annals of Oncology (15 papers)Cancers (8 papers)ESMO Open (6 papers)Therapeutic Advances in Medical Oncology (5 papers)European Journal of Cancer (4 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Claudio Vernieri
132 papers receiving 3.5k citations
Claudio Vernieri's Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 727
- Oncology 1.2k
- Physiology 495
- Aging 30
- Molecular Biology 1.1k
Countries citing papers authored by Claudio Vernieri
This map shows the geographic impact of Claudio Vernieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Vernieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Vernieri more than expected).
Fields of papers citing papers by Claudio Vernieri
This network shows the impact of papers produced by Claudio Vernieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Vernieri. The network helps show where Claudio Vernieri may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudio Vernieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fasting-mimicking diet and hormone therapy induce breast cancer regression Hit paper breakdown → | 2020 | 273 |
| 2 | 2019 | 178 | |
| 3 | 2019 | 177 | |
| 4 | 2011 | 159 | |
| 5 | 2016 | 159 | |
| 6 | 2016 | 156 | |
| 7 | 2020 | 125 | |
| 8 | 2021 | 118 | |
| 9 | 2022 | 97 | |
| 10 | 2021 | 92 | |
| 11 | 2018 | 86 | |
| 12 | 2020 | 76 | |
| 13 | 2018 | 75 | |
| 14 | 2020 | 65 | |
| 15 | 2022 | 61 | |
| 16 | 2018 | 60 | |
| 17 | 2024 | 60 | |
| 18 | 2021 | 59 | |
| 19 | 2020 | 55 | |
| 20 | 2018 | 50 |
About Claudio Vernieri
Claudio Vernieri is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Physiology and Genetics, having authored 138 papers that have together received 3.5k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (17 papers), Advanced Breast Cancer Therapies (16 papers), Breast Cancer Treatment Studies (15 papers), Neuroendocrine Tumor Research Advances (14 papers), HER2/EGFR in Cancer Research (12 papers), Cancer Genomics and Diagnostics (11 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Dietary Effects on Health (10 papers). The work is most often cited by research in Cancer Research (727 citations), Oncology (1.2k citations), Physiology (495 citations), Aging (30 citations) and Molecular Biology (1.1k citations). Claudio Vernieri has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Filippo Guglielmo Maria de Braud, Valter Daniel Longo, Francesca Ligorio, Riccardo Lobefaro, Marco Foiani, Andrea Ciliberto, Emma Zattarin, Giulia Bianchi, Giuseppe Capri and Fabrizio Villa. Their work appears in journals such as Annals of Oncology, Cancers, ESMO Open, Therapeutic Advances in Medical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.